Accurate somatic variant detection from formalin fixed, paraffin embedded tissue (FFPE) derived WES and WGS by DeepOmicsFFPE-PLUS, a sequence context-based transformer

Read full text
Authors: Wan Seop Kim, Ahwon Lee, Inyoung Kim, Seong-Eui Hong, Juyeong Park, Jongsung Lim, Eonji Noh, Minji Kim, Jiin Park, Jiwon Han, Misun Park, Heeyeon Cho
+4 more Jonghwan Shin, Yeongyu Yang, Soonmyung Paik, Dong-Hyuk Heo
Cited by: 0
References: 24

Abstract

Abstract Formalin-fixed paraffin-embedded (FFPE) tissues represent a vast archival resource for genomic studies, yet their utility remains constrained by fixation-induced DNA damage and subsequent sequencing artifacts. To comprehensively characterize and address this challenge, we analyzed matched FFPE and fresh-frozen tumor samples from two institutions, spanning different storage durations, DNA qualities, sequencing platforms (WES and WGS), exome capture kits, and somatic variant callers. We found that FFPE-induced artifacts exhibit strong batch- and age-specific patterns, with a predominance of C:G>T:A substitutions, which particularly complicate the accurate identification of low allele frequency true variants. Enzymatic repair methods partially alleviated these artifacts but remained insufficient. To overcome these limitations, we developed DeepOmicsFFPE-PLUS( https://github.com/Theragen-Bio/DeepOmicsFFPE-PLUS ), an advanced AI-based tool to accurately distinguish true somatic variants from FFPE-specific artifacts. DeepOmicsFFPE-PLUS demonstrated consistently superior performance across diverse conditions, achieving high sensitivity and specificity—even for low-frequency variants—outperforming existing tools. Application of our model to WGS data further enabled recovery of biologically relevant mutational signatures, including restoration of microsatellite instability (MSI)-associated signatures initially obscured by FFPE artifacts. Our findings underscore the necessity of artifact-aware variant calling in FFPE genomics and establish DeepOmicsFFPE-PLUS as a robust tool for artifact removal, enabling high-fidelity downstream analyses and personalized therapeutic target discovery.

Fields of Study & Subjects

Cancer Genomics and Diagnostics Genomics and Rare Diseases Genomics and Phylogenetic Studies

Publication details

Journal / source
bioRxiv (Cold Spring Harbor Laboratory)
Publication date
7 February 2026
Document type
Preprint